LifeNews.com reports on yet another success story of adult stem cell therapy, as opposed to embryonic stem cell research, which destroys human life and has yet to produce a single success.
The first study, conducted by scientists at the Minneapolis Heart Institute and reported in the journal Circulation, finds the research helping patients with angina, or pain due to artery blockage.
Meanwhile, researchers at Boston University Medical Center found that blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment.
There is no need to destroy human life through embryonic stem cell research when adult stem cell therapy has already produced dozens of successful treatments and continues to advance in new areas.
3 comments:
Does make one wonder why the insistence on the embryonic stem cell research, doesn't it? Let's see, could it be true that this is merely a step towards cloning?
Bob, it's great news that adult stem cells research is getting results. The more sick people we can help the better, I say.
But I disagree with you that these success stories indicate that we shouldn't explore embryonic stem cell research at all. It's possible that it could show just as many results as adults stem cell research. We won't know unless we try.
And Carrie, embryonic stem cell research has nothing to do with cloning. We're supporting it because we believe that it could one day result in treatments to help people suffering from illnesses. We keep pushing it because we want to help people. That's it.
Haggs, no doubt you are sincere, but misinformed. Embryonic stem cell research (ESR) has yielded no successful outcomes, either in treatments or insights to disease processes. What it has produced is problems with tissue rejection and malignant tumors.
The count of therapies coming from adult stem cell research (ASR) rises regularly and now numbers nearly eighty, from heart disease to leukemia to multiple myeloma, and holds promise for dozens more. There is no reason to invest public money into ESR on the vague hope of some future benefit, when a proven line of research already exists and presents no problem with rejection, tumor risks or ethical concerns.
I agree that the push for ESR has little to do with cloning. It does have a lot to do with abortion, however. If ERS became widespread there would be a demand for embryos and abortion clinics could provide the needed supply, thus putting a happy face on the gruesome practice of ripping embryos from the womb. There would probably be a financial benefit to abortionists, as well.
Finally, haggs, there are no laws preventing private labs from doing ESR, just no government funding. If there is so much promise to ESR why aren't private investors and drug companies pouring money into this research. Could it be they know that ESR is a scam for federal dollars?
Post a Comment